For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Calcitriol is a white, crystalline compound which occurs naturally in humans. It has a calculated molecular weight of 416.65 and is soluble in organic solvents but relatively insoluble in water. Calcitriol is a synthetic vitamin D analog which is active in the regulation of the absorption of calcium from the gastrointestinal tract and its utilization in the body. The report focus on the Calcitriol formulations market survey.
Scope of the Report:
This report focuses on the Calcitriol (CAS 32222-06-3) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Calcitriol can be classified as solution, capsule and others in terms of packaging method. capsule is the major kind of Calcitriol formulations. There are other types of Calcitriol formulations like ointment.
The largest producers of Calcitriol in the worldwide are Roche, CP Pharmaceutical Group, Sun Pharmaceutical Industries, Teva, West Ward Pharmaceuticals, Cadila Pharmaceuticals, Strides Arcolab and Akorn, which takes a combined revenue share of 91.61% in 2016.The largest producing area of Calcitriol are Europe, USA, India and China.
The worldwide market for Calcitriol (CAS 32222-06-3) is expected to grow at a CAGR of roughly 3.2% over the next five years, will reach 430 million US$ in 2023, from 350 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- CP Pharmaceutical Group
- Sun Pharmaceutical Industries
- West Ward Pharmaceuticals
- Cadila Pharmaceuticals
- Strides Arcolab
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Calcitriol Solution
- Calcitriol Capsule
Market Segment by Applications, can be divided into
- Renal Osteodystrophy
There are 15 Chapters to deeply display the global Calcitriol (CAS 32222-06-3) market.
Chapter 1, to describe Calcitriol (CAS 32222-06-3) Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Calcitriol (CAS 32222-06-3), with sales, revenue, and price of Calcitriol (CAS 32222-06-3), in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Calcitriol (CAS 32222-06-3), for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Calcitriol (CAS 32222-06-3) market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Calcitriol (CAS 32222-06-3) sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source